Drug-metabolizing enzymes, polymorphisms and interindividual response to environmental toxicants (Q34093080)

31 July 2017

title

Drug-metabolizing enzymes, polymorphisms and interindividual response to environmental toxicants (English)

1 reference

31 July 2017

D W Nebert

1

1 reference

31 July 2017

publication date

1 September 2000

1 reference

Clinical Chemistry and Laboratory Medicine

31 July 2017

language of work or name

English

0 references

published in

1 reference

31 July 2017

volume

38

1 reference

31 July 2017

issue

9

1 reference

31 July 2017

page(s)

857-861

1 reference

publication type of scholarly work

31 July 2017

review article

1 reference

Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.124

Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.124

Regulation of gene expression by reactive oxygen

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.124

Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.124

Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.124

Drug metabolism. Growth signal pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.124

Proposed role of drug-metabolizing enzymes: regulation of steady state levels of the ligands that effect growth, homeostasis, differentiation, and neuroendocrine functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.124

Drug-metabolizing enzymes in ligand-modulated transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.124

Biochemistry and molecular biology of the human CYP2C subfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.124

Cytochrome P450 2C is an EDHF synthase in coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.124

Inhibition of glutathione S-transferase zeta and tyrosine metabolism by dichloroacetate: a potential unifying mechanism for its altered biotransformation and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.124

Markedly Increased Constitutive CYP1A1 mRNA Levels in the Fertilized Ovum of the Mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.124

Tyrosine kinase inhibition: an approach to drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.124

BXR, an embryonic orphan nuclear receptor activated by a novel class of endogenous benzoate metabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.124

Toxicity of angular furanocoumarins to swallowtail butterflies: escalation in a coevolutionary arms race?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.124

Black swallowtail (Papilio polyxenes) alleles encode cytochrome P450s that selectively metabolize linear furanocoumarins

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.124

Pharmacogenetics: the slow, the rapid, and the ultrarapid

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.124

Suggestions for the nomenclature of human alleles: relevance to ecogenetics, pharmacogenetics and molecular epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.124

Evolution of the P450 gene superfamily: animal-plant 'warfare', molecular drive and human genetic differences in drug oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.124

Populations and genetic polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.124

Inactivating Mutations in the 25-Hydroxyvitamin D31α-Hydroxylase Gene in Patients with Pseudovitamin D–Deficiency Rickets

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.124

Genetics of vitamin D 1alpha-hydroxylase deficiency in 17 families

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.124

The molecular basis of Sjögren-Larsson syndrome: mutation analysis of the fatty aldehyde dehydrogenase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.124

Identification of three different truncating mutations in cytochrome P4501B1 (CYP1B1) as the principal cause of primary congenital glaucoma (Buphthalmos) in families linked to the GLC3A locus on chromosome 2p21

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.124

Miller-Dieker lissencephaly gene encodes a subunit of brain platelet-activating factor acetylhydrolase [corrected]

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.124

Smith-Lemli-Opitz syndrome is caused by mutations in the 7-dehydrocholesterol reductase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.124

21 January 2018

Identifiers

DOI

10.1515/CCLM.2000.124

1 reference

31 July 2017

1 reference